Methylprednisolone description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Methylprednisolone

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

METHYLPREDNISOLONE DESCRIPTION



Methylprednisolone



CLINICAL PHARMACOLOGY




INDICATIONS & USAGE


Endocrine Disorders




Rheumatic Disorders










Collagen Diseases




Dermatologic Diseases







Allergic States







Ophthalmic Diseases











Respiratory Diseases





Hematologic Disorders





Neoplastic Diseases



Edematous States

Gastrointestinal Diseases



Nervous System

Miscellaneous





METHYLPREDNISOLONE CONTRAINDICATIONS



WARNINGS





Usage in pregnancy


While on corticosteroid therapy patients should not be vaccinated against smallpox. Other immunization procedures should not be undertaken in patients who are on corticosteroids, especially on high doses, because of possible hazards of neurological complications and a lack of antibody response.




PRECAUTIONS

General Precautions








DOSAGE AND ADMINISTRATION



Information for the Patient


METHYLPREDNISOLONE ADVERSE REACTIONS


Fluid and Electrolyte Disturbances







Musculoskeletal








Gastrointestinal





Dermatologic







Neurological






Endocrine








Ophthalmic





Metabolic




DOSAGE & ADMINISTRATION


IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND THE RESPONSE OF THE PATIENT.

Multiple Sclerosis


ADT (Alternative Day Therapy)

















HOW SUPPLIED





STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Methylprednisolone

Methylprednisolone

Methylprednisolone

Methylprednisolone TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-884(NDC:51991-188)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METHYLPREDNISOLONE methylprednisolone 4 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
ANHYDROUS LACTOSE
MAGNESIUM STEARATE
cellulose, microcrystalline
STARCH, CORN
SODIUM LAURYL SULFATE
SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics

Color Size Imprint Code Shape
white 8 mm TL;001 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-884-05 21 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040189 2012-03-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.